PharmaCyte Biotech, Inc. (PMCB)
NASDAQ: PMCB · Real-Time Price · USD
0.700
-0.053 (-7.04%)
Mar 9, 2026, 4:00 PM EDT - Market closed
PharmaCyte Biotech Ratios and Metrics
Market cap in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 | Apr '21 Apr 30, 2021 |
| Market Capitalization | 8 | 9 | 18 | 51 | 48 | 42 | |
| Market Cap Growth | -38.66% | -52.51% | -64.81% | 5.50% | 14.27% | 16.41% | |
| Enterprise Value | -13 | -8 | -20 | -22 | -38 | 39 | |
| Last Close Price | 0.75 | 1.24 | 2.12 | 2.92 | 2.33 | 26.57 | |
| PE Ratio | - | 0.36 | - | - | - | - | |
| PB Ratio | 0.14 | 0.16 | 0.45 | 0.70 | 0.54 | 6.33 | |
| P/TBV Ratio | 0.23 | 0.17 | 0.69 | 0.74 | 0.56 | 13.50 | |
| Debt / Equity Ratio | - | - | - | - | - | 0.01 | |
| Net Debt / Equity Ratio | -0.56 | -0.30 | -1.27 | -0.94 | -0.95 | -0.32 | |
| Quick Ratio | 13.06 | 6.60 | 6.76 | 115.99 | 121.24 | 3.04 | |
| Current Ratio | 14.60 | 7.68 | 6.80 | 116.18 | 121.38 | 3.14 | |
| Return on Equity (ROE) | -17.68% | 67.08% | 0.60% | -5.31% | -8.78% | -60.35% | |
| Return on Assets (ROA) | -4.76% | -4.75% | -6.12% | -4.92% | -5.60% | -33.37% | |
| Return on Capital Employed (ROCE) | -7.80% | -8.40% | -12.40% | -8.90% | -4.90% | -54.20% | |
| Earnings Yield | -98.75% | 360.19% | 1.86% | -8.47% | -8.78% | -8.40% | |
| Buyback Yield / Dilution | 15.57% | 23.50% | 50.84% | -25.56% | -971.73% | -60.24% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.